SIGA Technologies
SIGA Technologies, Inc. engages in the development and commercialization of solutions for unmet medical needs and biothreats in the United States. Its lead product is TPOXX, an orally administered antiviral drug for treating orthopoxvirus infections. SIGA Technologies, Inc. was founded in 1995 and is headquartered in New York, New...
Last updated on
About SIGA Technologies
Founded
1995Estimated Revenue
$100M-$250MEmployees
51-250Funding / Mkt. Cap
$13MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
32Location
City
New York CityState
New YorkCountry
United StatesTech Stack (55)
Analytics and Tracking
Widgets
Apple Whitelist
MonsterInsights
Slack
Cloudflare Bot Manager
Yoast Plugins
Wordpress Plugins
Typekit
Google Font API
WP PageNavi
AddThis
reCAPTCHA
Sitelinks Search Box
COVID-19
Simple Social Icons
Google Tag Manager
US Privacy User Signal Mechanism
Azure Active Directory
CrUX Dataset
Cloudflare Radar
DocuSign
Wix Pro Gallery
